These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 15284297)
1. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. Sharples EJ; Patel N; Brown P; Stewart K; Mota-Philipe H; Sheaff M; Kieswich J; Allen D; Harwood S; Raftery M; Thiemermann C; Yaqoob MM J Am Soc Nephrol; 2004 Aug; 15(8):2115-24. PubMed ID: 15284297 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats. Caetano AM; Vianna Filho PT; Castiglia YM; Golim MA; de Souza AV; de Carvalho LR; Deffune E; de Oliveira C; Vianna PT Transplant Proc; 2011 Dec; 43(10):3618-21. PubMed ID: 22172815 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney. Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Cuzzocrea S; Thiemermann C Eur J Pharmacol; 2004 Oct; 503(1-3):173-83. PubMed ID: 15496312 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. Chong ZZ; Lin SH; Kang JQ; Maiese K J Neurosci Res; 2003 Mar; 71(5):659-69. PubMed ID: 12584724 [TBL] [Abstract][Full Text] [Related]
6. Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats. Cassis P; Azzollini N; Solini S; Mister M; Aiello S; Cugini D; Scudeletti P; Gagliardini E; Abbate M; Gallon L; Remuzzi G; Noris M Transplantation; 2011 Aug; 92(3):271-9. PubMed ID: 21705971 [TBL] [Abstract][Full Text] [Related]
7. Regulation of caspase-3 and -9 activation in oxidant stress to RTE by forkhead transcription factors, Bcl-2 proteins, and MAP kinases. Kaushal GP; Liu L; Kaushal V; Hong X; Melnyk O; Seth R; Safirstein R; Shah SV Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1258-68. PubMed ID: 15304372 [TBL] [Abstract][Full Text] [Related]
8. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972 [TBL] [Abstract][Full Text] [Related]
9. Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury. Rusai K; Prókai A; Szebeni B; Fekete A; Treszl A; Vannay A; Müller V; Reusz G; Heemann U; Lutz J; Tulassay T; Szabó AJ Biochem Pharmacol; 2010 Apr; 79(8):1173-81. PubMed ID: 19961832 [TBL] [Abstract][Full Text] [Related]
10. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Johnson DW; Pat B; Vesey DA; Guan Z; Endre Z; Gobe GC Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197 [TBL] [Abstract][Full Text] [Related]
11. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271 [TBL] [Abstract][Full Text] [Related]
12. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748 [TBL] [Abstract][Full Text] [Related]
13. Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis. Imamura R; Isaka Y; Ichimaru N; Takahara S; Okuyama A Biochem Biophys Res Commun; 2007 Feb; 353(3):786-92. PubMed ID: 17196938 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation. Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412 [TBL] [Abstract][Full Text] [Related]
15. AChE deficiency or inhibition decreases apoptosis and p53 expression and protects renal function after ischemia/reperfusion. Ye W; Gong X; Xie J; Wu J; Zhang X; Ouyang Q; Zhao X; Shi Y; Zhang X Apoptosis; 2010 Apr; 15(4):474-87. PubMed ID: 20054652 [TBL] [Abstract][Full Text] [Related]
16. Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion. Kher A; Meldrum KK; Hile KL; Wang M; Tsai BM; Turrentine MW; Brown JW; Meldrum DR J Thorac Cardiovasc Surg; 2005 Sep; 130(3):662-9. PubMed ID: 16153910 [TBL] [Abstract][Full Text] [Related]
17. Asialoerythropoietin has strong renoprotective effects against ischemia-reperfusion injury in a murine model. Okada T; Sawada T; Kubota K Transplantation; 2007 Aug; 84(4):504-10. PubMed ID: 17713435 [TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Müller C; Dünschede F; Koch E; Vollmar AM; Kiemer AK Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G769-78. PubMed ID: 12816756 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model. Hochhauser E; Pappo O; Ribakovsky E; Ravid A; Kurtzwald E; Cheporko Y; Lelchuk S; Ben-Ari Z Apoptosis; 2008 Jan; 13(1):77-86. PubMed ID: 18085440 [TBL] [Abstract][Full Text] [Related]
20. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. Yang CW; Li C; Jung JY; Shin SJ; Choi BS; Lim SW; Sun BK; Kim YS; Kim J; Chang YS; Bang BK FASEB J; 2003 Sep; 17(12):1754-5. PubMed ID: 12958199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]